Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
Good things come in small packages: roles of exosomes as therapy delivery tools, therapeutic targets and potential biomarkers
March 23, 2021
December 3, 2020
Uncovering the Heterogeneity of Extracellular Vesicles Derived From Amniotic Epithelial Cells Associated With Pregnancy Complications and Culture Conditions
November 10, 2020
October 26, 2020